Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PSG5 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | MS4A1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | BX004987.1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
mRNA | ADRB2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
mRNA | BFSP2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | NDUFV1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | UTP11 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
mRNA | BRD4 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | MAP7D3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | TMEM106A | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |